# BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling

> **NCT00252213** · PHASE1 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 24 (—)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Human BNP

## Key facts

- **NCT ID:** NCT00252213
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 24 (—)
- **Why stopped:** recruitment of subjects was halted prematurely. recruiting subjects halted prematurely
- **Last updated:** 2009-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252213, "BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00252213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*